Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Northwest Biotherapeutics (NWBO) Net Income towards Common Stockholders (2016 - 2025)

Northwest Biotherapeutics (NWBO) has 16 years of Net Income towards Common Stockholders data on record, last reported at -$27.2 million in Q3 2025.

  • For Q3 2025, Net Income towards Common Stockholders fell 39.35% year-over-year to -$27.2 million; the TTM value through Sep 2025 reached -$91.2 million, down 28.46%, while the annual FY2024 figure was -$85.2 million, 32.34% down from the prior year.
  • Net Income towards Common Stockholders reached -$27.2 million in Q3 2025 per NWBO's latest filing, down from -$15.9 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$4.1 million in Q1 2021 and bottomed at -$32.9 million in Q3 2022.
  • Average Net Income towards Common Stockholders over 5 years is -$18.8 million, with a median of -$17.1 million recorded in 2024.
  • The widest YoY moves for Net Income towards Common Stockholders: up 93.26% in 2021, down 251.25% in 2021.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$13.1 million in 2021, then crashed by 116.18% to -$28.3 million in 2022, then skyrocketed by 49.4% to -$14.3 million in 2023, then plummeted by 99.02% to -$28.5 million in 2024, then increased by 4.61% to -$27.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income towards Common Stockholders were -$27.2 million in Q3 2025, -$15.9 million in Q2 2025, and -$19.6 million in Q1 2025.